Application of data mining approaches to drug delivery.

Computational approaches play a key role in all areas of the pharmaceutical industry from data mining, experimental and clinical data capture to pharmacoeconomics and adverse events monitoring. They will likely continue to be indispensable assets along with a growing library of software applications. This is primarily due to the increasingly massive amount of biology, chemistry and clinical data, which is now entering the public domain mainly as a result of NIH and commercially funded projects. We are therefore in need of new methods for mining this mountain of data in order to enable new hypothesis generation. The computational approaches include, but are not limited to, database compilation, quantitative structure activity relationships (QSAR), pharmacophores, network visualization models, decision trees, machine learning algorithms and multidimensional data visualization software that could be used to improve drug delivery after mining public and/or proprietary data. We will discuss some areas of unmet needs in the area of data mining for drug delivery that can be addressed with new software tools or databases of relevance to future pharmaceutical projects.

[1]  R. Ulrich The toxicogenomics of nuclear receptor agonists. , 2003, Current opinion in chemical biology.

[2]  Chris North,et al.  Visualizing Biological Pathways: Requirements Analysis, Systems Evaluation and Research Agenda , 2005, Inf. Vis..

[3]  Brian K. Shoichet,et al.  Virtual screening of chemical libraries , 2004, Nature.

[4]  S. Ekins,et al.  Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[5]  J. Lehmann,et al.  Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. , 2002, Molecular pharmacology.

[6]  T. Nikolskaya,et al.  A COMBINED APPROACH TO DRUG METABOLISM AND TOXICITY ASSESSMENT , 2006, Drug Metabolism and Disposition.

[7]  Tatiana Nikolskaya,et al.  Early prediction of drug metabolism and toxicity: systems biology approach and modeling. , 2004, Drug discovery today.

[8]  Y. Martin,et al.  3D database searching in drug design. , 1992, Journal of medicinal chemistry.

[9]  N. Anderson,et al.  Proteome and proteomics: New technologies, new concepts, and new words , 1998, Electrophoresis.

[10]  Sean Ekins,et al.  Computer Applications in Pharmaceutical Research and Development , 2008 .

[11]  R. Tongiani,et al.  Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. , 1998, Life sciences.

[12]  Pravin Chaturvedi,et al.  Design principles for orally bioavailable drugs , 1996 .

[13]  Sean Ekins,et al.  Generation and validation of rapid computational filters for cyp2d6 and cyp3a4. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[14]  I. Enyedy,et al.  Discovery of a novel dopamine transporter inhibitor, 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone, as a potential cocaine antagonist through 3D-database pharmacophore searching. Molecular modeling, structure-activity relationships, and behavioral pharmacological studies. , 2000, Journal of medicinal chemistry.

[15]  Sean Ekins,et al.  A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM , 2005, Drug Metabolism and Disposition.

[16]  Kenneth A. Giuliano,et al.  High content screening : a powerful approach to systems cell biology and drug discovery , 2007 .

[17]  A. Fliri,et al.  Biological spectra analysis: Linking biological activity profiles to molecular structure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Philip E. Bourne,et al.  Will a Biological Database Be Different from a Biological Journal? , 2005, PLoS Comput. Biol..

[19]  Maurizio Fermeglia,et al.  Polyamidoamine (Yet Not PAMAM) dendrimers as bioinspired materials for drug delivery: structure-activity relationships by molecular simulations. , 2004, Biomacromolecules.

[20]  Chris de Graaf,et al.  Cytochrome p450 in silico: an integrative modeling approach. , 2005, Journal of medicinal chemistry.

[21]  Peter W. Sprague,et al.  CATALYST Pharmacophore Models and Their Utility As Queries for Searching 3D Databases , 2007 .

[22]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[23]  Sean Ekins,et al.  Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. , 2005, Trends in pharmacological sciences.

[24]  K. Chung,et al.  Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport. , 2004, American journal of respiratory cell and molecular biology.

[25]  Tudor I. Oprea,et al.  Toward minimalistic modeling of oral drug absorption. , 1999, Journal of molecular graphics & modelling.

[26]  Silvio Albertini,et al.  Modulation of gene and protein expression by carbon tetrachloride in the rat liver. , 2002, Toxicology and applied pharmacology.

[27]  Robert P Tonge,et al.  Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  Yudong D. He,et al.  Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression. , 2004, Molecular pharmacology.

[29]  Donna L Mendrick,et al.  Toxicogenomics: a new revolution in drug safety. , 2002, Drug discovery today.

[30]  Sean Ekins,et al.  In silico ADME/Tox: the state of the art. , 2002, Journal of molecular graphics & modelling.

[31]  Bryan L Roth,et al.  Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery. , 2004, Pharmacology & therapeutics.

[32]  T. Nikolskaya,et al.  Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms , 2006, Xenobiotica; the fate of foreign compounds in biological systems.

[33]  Milton H. Saier,et al.  TCDB: the Transporter Classification Database for membrane transport protein analyses and information , 2005, Nucleic Acids Res..

[34]  T. Uchiumi,et al.  Differential regulation of the human MRP2 and MRP3 gene expression by glucocorticoids , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  S. Ekins Systems-ADME/Tox: resources and network approaches. , 2006, Journal of pharmacological and toxicological methods.

[36]  M. Relling,et al.  CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differences. , 2000, The Journal of pharmacology and experimental therapeutics.

[37]  James W. McFarland,et al.  A Novel Approach for Prediction of Intestinal Absorption of Drugs in Humans based on Hydrogen Bond Descriptors and Structural Similarity , 2001 .

[38]  A. Fliri,et al.  Biospectra analysis: model proteome characterizations for linking molecular structure and biological response. , 2005, Journal of medicinal chemistry.

[39]  Johann Gasteiger,et al.  InfVis - Platform-Independent Visual Data Mining of Multidimensional Chemical Data Sets , 2005, J. Chem. Inf. Model..

[40]  Mitchell N. Cayen,et al.  A guide to drug discovery: Making Better Drugs: Decision Gates in Non-Clinical Drug Development , 2003, Nature Reviews Drug Discovery.

[41]  Christopher A. Lipinski,et al.  Capter 11 Filtering in Drug Discovery , 2005, Annual Reports in Computational Chemistry.

[42]  Sean Ekins,et al.  Pathway mapping tools for analysis of high content data. , 2007, Methods in molecular biology.

[43]  Takayuki Itoh,et al.  Visualization of Large-Scale Aqueous Solubility Data Using a Novel Hierarchical Data Visualization Technique , 2006, J. Chem. Inf. Model..

[44]  Elizabeth A. Colbourn,et al.  Computers in Pharmaceutical Formulation , 2006 .

[45]  K. Iseki,et al.  A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction. , 1998, Journal of pharmaceutical sciences.

[46]  J L Katz,et al.  2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors. , 2000, Journal of medicinal chemistry.

[47]  D. Cvetkovic,et al.  Eigenspaces of graphs: Bibliography , 1997 .

[48]  Alain Calvet,et al.  Molecular Property eXplorer: A Novel Approach to Visualizing SAR Using Tree-Maps and Heatmaps , 2005, J. Chem. Inf. Model..

[49]  H. Koepsell,et al.  Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. , 2005, American journal of respiratory cell and molecular biology.

[50]  Kenneth M. Merz,et al.  Computation of the physio‐chemical properties and data mining of large molecular collections , 2002, J. Comput. Chem..

[51]  W. Pardridge,et al.  Blood—Brain Barrier Genomics , 2001, Methods in molecular medicine.

[52]  M C Nicklaus,et al.  HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching. , 1997, Journal of medicinal chemistry.

[53]  Kenneth M. Johnson,et al.  Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[54]  Pierre R. Bushel,et al.  Chemical effects in biological systems (CEBS) object model for toxicology data, SysTox-OM: design and application , 2006, Bioinform..

[55]  J. Sahi,et al.  Metabolism and transporter-mediated drug-drug interactions of the endothelin-A receptor antagonist CI-1034. , 2006, Chemico-biological interactions.

[56]  Aidong Zhang,et al.  VizStruct for visualization of genome-wide SNP analyses , 2006, Bioinform..

[57]  S. Ekins,et al.  Progress in predicting human ADME parameters in silico. , 2000, Journal of pharmacological and toxicological methods.

[58]  Stephen H. Friend,et al.  Toxicogenomics and drug discovery: will new technologies help us produce better drugs? , 2002, Nature Reviews Drug Discovery.

[59]  J J Baldwin,et al.  Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.

[60]  Leslie Z. Benet,et al.  Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System , 2004, Pharmaceutical Research.

[61]  Qutayba Hamid,et al.  Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. , 2003, The Journal of clinical investigation.

[62]  Peter C. Jurs,et al.  Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..

[63]  U Norinder,et al.  Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.

[64]  S. Ekins,et al.  Comparative Pharmacophore Modeling of Organic Anion Transporting Polypeptides: A Meta-Analysis of Rat Oatp1a1 and Human OATP1B1 , 2005, Journal of Pharmacology and Experimental Therapeutics.

[65]  G. Ecker,et al.  Targeting drug-efflux pumps -- a pharmacoinformatic approach. , 2005, Acta biochimica Polonica.

[66]  Sean Ekins,et al.  A Ligand-Based Approach to Understanding Selectivity of Nuclear Hormone Receptors PXR, CAR, FXR, LXRα, and LXRβ , 2002, Pharmaceutical Research.

[67]  Akhilesh Pandey,et al.  From biological databases to platforms for biomedical discovery. , 2003, Trends in biotechnology.

[68]  H O Villar,et al.  Protein affinity map of chemical space. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[69]  M. Rothenberg,et al.  Arginine in asthma and lung inflammation. , 2004, The Journal of nutrition.

[70]  Yvonne C. Martin,et al.  A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists , 1993, J. Comput. Aided Mol. Des..

[71]  Werner J Geldenhuys,et al.  Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system. , 2006, Life sciences.

[72]  D. E. Clark,et al.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.

[73]  S L Lin,et al.  Identification of novel farnesyl protein transferase inhibitors using three-dimensional database searching methods. , 1997, Journal of medicinal chemistry.

[74]  Michael D Waters,et al.  Database development in toxicogenomics: issues and efforts. , 2004, Environmental health perspectives.

[75]  T. Ideker,et al.  Modeling cellular machinery through biological network comparison , 2006, Nature Biotechnology.

[76]  D. Postma,et al.  ATP-binding cassette (ABC) transporters in normal and pathological lung , 2005, Respiratory research.

[77]  M F Engels,et al.  Smart screening: approaches to efficient HTS. , 2001, Current opinion in drug discovery & development.

[78]  E. Dougherty,et al.  Unraveling gene-gene interactions regulated by ligands of the aryl hydrocarbon receptor. , 2004, Environmental health perspectives.

[79]  W. L. Jorgensen The Many Roles of Computation in Drug Discovery , 2004, Science.

[80]  Sean Ekins,et al.  Modeling of active transport systems. , 2002, Advanced drug delivery reviews.

[81]  Han van de Waterbeemd,et al.  Computer-Assisted Lead Finding and Optimization , 1997 .

[82]  I. Enyedy,et al.  Pharmacophore-based discovery of 3,4-disubstituted pyrrolidines as a novel class of monoamine transporter inhibitors. , 2001, Bioorganic & medicinal chemistry letters.

[83]  Ahlberg Visual exploration of HTS databases: bridging the gap between chemistry and biology. , 1999, Drug discovery today.

[84]  Massimo Bertozzi,et al.  Vision-based pedestrian detection: will ants help? , 2002, Intelligent Vehicle Symposium, 2002. IEEE.

[85]  Ian T. Nabney,et al.  Data Visualization during the Early Stages of Drug Discovery , 2006, J. Chem. Inf. Model..

[86]  E. Shorter Looking backwards: a possible new path for drug discovery in psychopharmacology , 2002, Nature Reviews Drug Discovery.

[87]  Xin Chen,et al.  ADME-AP: a database of ADME associated proteins , 2002, Bioinform..

[88]  Charles M. Perou Show me the data! , 2001, Nature Genetics.

[89]  Gerhard Klebe,et al.  AffinDB: a freely accessible database of affinities for protein–ligand complexes from the PDB , 2005, Nucleic Acids Res..

[90]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[91]  Qing Yan,et al.  Human membrane transporter database: A web-accessible relational database for drug transport studies and pharmacogenomics , 2000, AAPS PharmSci.

[92]  Sean Ekins,et al.  Development of Computational Models for Enzymes, Transporters, Channels, and Receptors Relevant to ADME/Tox , 2004 .

[93]  Tudor I. Oprea,et al.  Oncology exploration: charting cancer medicinal chemistry space. , 2006, Drug discovery today.

[94]  D. Thompson,et al.  Application of proteomic technologies in the drug development process. , 2003, Toxicology letters.

[95]  Daniel A. Gschwend,et al.  ArQiologist: An Integrated Decision Support Tool for Lead Optimization , 2005, J. Chem. Inf. Model..

[96]  A. Fliri,et al.  Analysis of drug-induced effect patterns to link structure and side effects of medicines , 2005, Nature chemical biology.

[97]  Stephen A. Wring,et al.  Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs , 2002, Journal of Pharmacology and Experimental Therapeutics.

[98]  Chris Orsi,et al.  Integrative bioinformatics: making sense of the networks. , 2004, Drug discovery today. Technologies.

[99]  Solomon Nwaka,et al.  Science & society: Virtual drug discovery and development for neglected diseases through public–private partnerships , 2003, Nature Reviews Drug Discovery.

[100]  R. Blakely,et al.  Pharmacological profile of neuroleptics at human monoamine transporters. , 1999, European journal of pharmacology.

[101]  R. Evans,et al.  Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. , 2003, Molecular endocrinology.

[102]  P. Meier,et al.  The superfamily of organic anion transporting polypeptides. , 2003, Biochimica et biophysica acta.

[103]  David M. Rocke,et al.  Predicting ligand binding to proteins by affinity fingerprinting. , 1995, Chemistry & biology.

[104]  Ben van Ommen,et al.  Bromobenzene-induced hepatotoxicity at the transcriptome level. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[105]  S. Ekins,et al.  Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates. , 2002, Molecular pharmacology.

[106]  N. Ozawa,et al.  Transporter Database, TP-Search: A Web-Accessible Comprehensive Database for Research in Pharmacokinetics of Drugs , 2004, Pharmaceutical Research.

[107]  Tomoko Niwa,et al.  Using General Regression and Probabilistic Neural Networks To Predict Human Intestinal Absorption with Topological Descriptors Derived from Two-Dimensional Chemical Structures , 2003, J. Chem. Inf. Comput. Sci..

[108]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[109]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[110]  U. Norinder,et al.  Computational approaches to the prediction of the blood-brain distribution. , 2002, Advanced drug delivery reviews.

[111]  Sean Ekins,et al.  Comprehensive computational assessment of ADME properties using mapping techniques. , 2005, Current drug discovery technologies.

[112]  Charles J. Manly,et al.  The impact of informatics and computational chemistry on synthesis and screening. , 2001, Drug discovery today.

[113]  S. Ekins,et al.  Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. , 2003, Molecular pharmacology.

[114]  D W Zaharevitz,et al.  The discovery of novel, structurally diverse protein kinase C agonists through computer 3D-database pharmacophore search. Molecular modeling studies. , 1994, Journal of medicinal chemistry.

[115]  C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[116]  Andrew Smellie,et al.  Identification of Common Functional Configurations Among Molecules , 1996, J. Chem. Inf. Comput. Sci..

[117]  M. Fielden,et al.  Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. , 2005, Journal of biotechnology.

[118]  JD Tugwood,et al.  Biology and toxicology of PPARg ligands , 2002 .

[119]  U Norinder,et al.  Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[120]  Thomas Lengauer,et al.  Novel technologies for virtual screening. , 2004, Drug discovery today.

[121]  M. Rawlins Cutting the cost of drug development? , 2004, Nature Reviews Drug Discovery.

[122]  Samir Mitragotri,et al.  Design principles of chemical penetration enhancers for transdermal drug delivery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[123]  R. Blakely,et al.  Pharmacological profile of antidepressants and related compounds at human monoamine transporters. , 1997, European journal of pharmacology.

[124]  P. Lord Progress in applying genomics in drug development. , 2003, Toxicology letters.

[125]  Shayne C. Gad,et al.  Drug Discovery Handbook , 1994 .

[126]  Jerry Lanfear Dealing with the data deluge , 2002, Nature Reviews Drug Discovery.

[127]  Dragos Horvath,et al.  Neighborhood Behavior of in Silico Structural Spaces with Respect to in Vitro Activity Spaces-A Novel Understanding of the Molecular Similarity Principle in the Context of Multiple Receptor Binding Profiles , 2003, J. Chem. Inf. Comput. Sci..

[128]  S. Ekins,et al.  STRUCTURAL BIOLOGY AND FUNCTION OF SOLUTE TRANSPORTERS: IMPLICATIONS FOR IDENTIFYING AND DESIGNING SUBSTRATES , 2002, Drug metabolism reviews.

[129]  J. Lehmann,et al.  An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.

[130]  David J Diller,et al.  Fast small molecule similarity searching with multiple alignment profiles of molecules represented in one-dimension. , 2005, Journal of medicinal chemistry.

[131]  Sean Ekins,et al.  In vitro and pharmacophore insights into CYP3A enzymes. , 2003, Trends in pharmacological sciences.

[132]  B Testa,et al.  Predicting blood-brain barrier permeation from three-dimensional molecular structure. , 2000, Journal of medicinal chemistry.

[133]  K. Nakata,et al.  A Nuclear Receptor Database that Maps Pathways to Diseases , 2002 .

[134]  G. Ecker,et al.  Lead Identification for Modulators of Multidrug Resistance based on in silico Screening with a Pharmacophoric Feature Model , 2004, Archiv der Pharmazie.

[135]  R. Evans,et al.  A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection. , 2003, Current drug metabolism.

[136]  Peter W Swaan,et al.  Computational approaches to modeling drug transporters. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[137]  J. Kuromitsu,et al.  Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists. , 2002, Biochemical and biophysical research communications.

[138]  J. Klein,et al.  Overview of proteomics. , 2004, Contributions to nephrology.

[139]  C. Moyes,et al.  3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists. , 2001, Journal of medicinal chemistry.

[140]  R. Tennant,et al.  Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base. , 2002 .

[141]  Bruno Boulanger,et al.  Towards a new age of virtual ADME/TOX and multidimensional drug discovery , 2002, J. Comput. Aided Mol. Des..

[142]  P. Sprague Automated chemical hypothesis generation and database searching with Catalyst , 1995 .

[143]  Narayanan Surendran,et al.  Implementation of an ADME enabling selection and visualization tool for drug discovery. , 2004, Journal of pharmaceutical sciences.

[144]  L. Lesko,et al.  Microarray data—the US FDA, industry and academia , 2003, Nature Biotechnology.

[145]  H. Kubinyi Drug research: myths, hype and reality , 2003, Nature Reviews Drug Discovery.

[146]  R Abagyan,et al.  Rational discovery of novel nuclear hormone receptor antagonists , 2000, Proc. Natl. Acad. Sci. USA.

[147]  Qiong Gao,et al.  pSTIING: a ‘systems’ approach towards integrating signalling pathways, interaction and transcriptional regulatory networks in inflammation and cancer , 2005, Nucleic Acids Res..